New Delhi, September 4, 2025 – A Delhi based  Men’s health tech platform, , RxMen raises Rs. 5 crores in Seed round led by Inflection Point Ventures, one of India’s largest Angel investing platforms. With this funding, RxMen aims to achieve a positive EBITDA by October 2025. In addition, the funds will be used for brand building, launching RxMen-branded products and setting up co-branded clinics. The round also saw participation from SPA Family Ventures, Ankit Goel, Seven Square Ventures and received a grant from the Prosus Group.

Over the last 20 months, RxMen has recorded a remarkable 100x revenue growth and is projecting an ARR (Annual Recurring Revenue) of $1.7 million by FY26, projecting an MRR (Monthly Recurring Revenue) of $70,000 in August 2025. The company has gained national visibility by being featured on Shark Tank India and earned credibility by receiving a grant from the prestigious Prosus Group (a global investment company known for backing high-growth startups).

Vinay Bansal, Founder, IPV adds, "Often men’s issues related to sexual health, skin and hair are overlooked. Add to it the stigma of discussing such issues publicly makes it very difficult for Indian men to access good quality healthcare and get treatment for their problems. RxMen provides an all in one men’s health platform designed specifically for their needs which addresses these issues in a holistic manner. By offering solutions to challenges that are typically neglected and rarely spoken about, RxMen empowers men to normalize these issues and tackle them with confidence.”

Shailja Mittal, Founder and CEO of RxMen said, “At RxMen, our focus has always been on building a clinical, root-cause platform for men’s health. This fundraise helps us strengthen that mission, expanding care beyond sexual health into stress, sleep, hair, skin, and weight, and continue creating a credible ecosystem where men can finally access the right treatment and support.”

RxMen is founded by Shailja Mittal, a B.Tech graduate from Delhi College of Engineering and a second-time entrepreneur. Before starting RxMen, she founded Koala Kabs, India’s first women-driven cab service. She has been recognised with several honours, including BW 40 Under 40, the Digital Women Award, and a feature on Shark Tank India.

RxMen has developed a proprietary Sexual Health Index (SHI), which is currently under clinical validation at IIT Jodhpur. They have used insights from more than 25,000 anonymized consultations to create the basis of the SHI. The scale was developed with the support of senior clinicians such as Dr. Siddharth Chowdhury and Dr. Anita Shyam and refined through real patient cases. RxMen also works with a network of more than 25 specialists, including urologists, sexologists, psychiatrists, and therapists, adding depth and credibility to its clinical practice. RxMen has achieved an impressive 95% success rate as reported by SHI (Sexual Health Index) outcomes tracking.

RxMen is currently conducting over 6,000 consultations per month, supported by a team of more than 30 clinicians across urology, sexology, psychiatry, and therapy. Its patients come from Tier 1, Tier 2, and Tier 3 cities, reflecting a wide reach across India. Highlighting its popularity across diverse markets and a clear upward trajectory of growth.

The global health and wellness market is estimated at USD 4.5 trillion with India’s health and wellness market industry valued at USD 155 billion as per the IMARC 2024 report. It is projected to grow up to nearly USD 257 billion by 2033, at a CAGR of 5.3%. RxMen estimates 25% of India’s health and wellness market is specific to men and is valued at approximately USD 39 billion. RxMen’s focus is on urban, digital-first Indian men between the ages of 25 and 45, a segment that represents close to 30 million people.

About RxMen:

RxMen, founded in 2023 by Shailja Mittal, is India’s first full-stack men’s health platform. We deliver root-cause, doctor-led care, starting with sexual health, and now expanding across sexual, mental, skin, hair and sleep, building the male equivalent of gynaecology.

About Inflection Point Ventures:

Inflection Point Ventures (IPV) is an angel investing platform with over 23,500+ CXOs, HNIs, and Professionals to together invest in startups. The firm supports new-age entrepreneurs by providing them with monetary & experiential capital and connecting them with a diverse group of investors. IPV has launched a $50 Mn CAT 2 VC fund, Physis Capital, to invest in Pre-Series A to Series B growth-stage start-ups. The fund has already deployed capital in six startups so far, with a few deals in advanced stages of pipeline.